Search engines could prioritise GB-registered pharmacies to tackle online fakes, report from regulator says The General Pharmaceutical Council calls on Big Tech companies to do “much more to tackle this major patient safety threat”.…
Assisted dying bill defeated in House of Commons The Terminally Ill Adults (End of Life) Bill has been voted down at its second reading in the House of Commons, with 286 MPs voting against the Bill, while 270 MPs voted for it.…
Pharmacy and industry bodies publish guidance on barcodes for individual medicines doses across Europe The proposed approach would ensure that individual units of medicines given to patients in Europe would carry their own barcode, instead of just the outer box.…
Manufacturers’ body reports £2bn boost to pharma investment in UK in the past year The Association of the British Pharmaceutical Industry highlighted 16 financial commitments made by 13 pharmaceutical companies between October 2025 and July 2026, totalling £1.98bn.…
Assessing authorship, study purpose and journals when evaluating clinical studies Part of a comprehensive series showing how to evaluate a clinical study or research paper. This article focuses on why it is important to consider the authors’ background, aims and where the article was published.…
Next frontier: crystallising the future of medicines The UK is taking a lead in creating the regulatory framework needed to manufacture medicines in space, which is a move that could pave the way for improved treatments for cancer and rare diseases.…
ICB to use pharmacists for penicillin allergy de-labelling following patient death A patient died as a result of a hypoxic brain injury, which was caused by medication given in the peri-operative period of an elective procedure in the days before her death.…
From liquids to solids: resetting paediatric prescribing for a safer, sustainable future Pharmacists can lead an evidence-based shift to make convenient solid oral dosage forms the new normal.…
What causes medicines shortages: the supply chain explained Record numbers of price concessions over the past year indicate increasing shortages. But what’s behind them — global events, commercial decisions or confusion about where stock is located?…
Regulator encourages development of microbiome-based medicines The Medicines and Healthcare products Regulatory Agency’s position paper is aimed to provide clarity on microbiome medicinal products and how to bring them forward “with confidence”.…
